Cloned (Comment) | Organism |
---|---|
expression in HEK-293 cell | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
A513T | mutant associated with congenital myasthenic syndrome, shows enhanced interaction with heat shock proteins HSC/HSP70 and HSP90 and increased sensitivity to heat shock protein inhibition | Homo sapiens |
P17A/P19A | mutant shows enhanced interaction with heat shock proteins HSC/HSP70 and HSP90 and increased sensitivity to heat shock protein inhibition | Homo sapiens |
V18M | mutant associated with congenital myasthenic syndrome, shows enhanced interaction with heat shock proteins HSC/HSP70 and HSP90 and increased sensitivity to heat shock protein inhibition | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | P28329 | - |
- |
Synonyms | Comment | Organism |
---|---|---|
ChAT | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
physiological function | enzyme interacts with heat shock proteins HSC/HSP70 and HSP90. Inhibition of heat shock proteins reduces cellular ChAT activity and solubility, and enhances the ubiquitination and proteasome-dependent loss of ChAT protein. The effects of HSP inhibition are greater for mutant ChAT proteins P17A/P19A and congenital myasthenic syndrome-related mutants V18M and A513T compared to wild-type ChAT. siRNA-mediated knock-down of E3 ubiquitin ligase CHIP has no effect on either wild-type or mutant ChAT protein levels. Inhibition of the endoplasmic reticulum and heat shock protein-associated cochaperone p97/VCP prevents degradation of ubiquitinated ChAT | Homo sapiens |